scholarly journals The Impact of a Culturally Tailored Patient Navigator Program on Cervical Cancer Prevention in Latina Women

2013 ◽  
Vol 22 (5) ◽  
pp. 426-431 ◽  
Author(s):  
Sanja Percac-Lima ◽  
Carly S. Benner ◽  
Raymond Lui ◽  
Leslie S. Aldrich ◽  
Sarah A. Oo ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Prevention ◽  
Cervical Cancer Prevention ◽  
Patient Navigator ◽  
Latina Women ◽  
Culturally Tailored ◽  
The Impact

scholarly journals The impact of the social environment on Zambian cervical cancer prevention practices

BMC Cancer ◽  
2018 ◽  
Vol 18 (1) ◽  
Author(s):  
Anayawa Nyambe ◽  
Jarl K. Kampen ◽  
Stridutt K. Baboo ◽  
Guido Van Hal
Keyword(s):  
Cervical Cancer ◽  
Cancer Prevention ◽  
Social Environment ◽  
Cervical Cancer Prevention ◽  
The Social ◽  
The Impact

scholarly journals The impact of human papillomavirus vaccination on cervical cancer prevention efforts

2009 ◽  
Vol 114 (2) ◽  
pp. 360-364 ◽  
Author(s):  
L. Stewart Massad ◽  
Mark Einstein ◽  
Evan Myers ◽  
Cosette M. Wheeler ◽  
Nicolas Wentzensen ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Human Papillomavirus ◽  
Cancer Prevention ◽  
Cervical Cancer Prevention ◽  
Human Papillomavirus Vaccination ◽  
The Impact

Assessment of the Impact of Cervical Cancer Prevention Educational Videos for Quechua- and Spanish-Speaking Peruvian Women

2009 ◽  
Vol 13 (4) ◽  
pp. 244-251 ◽  
Author(s):  
Daron G. Ferris ◽  
Christina Hupman ◽  
Jennifer L. Waller ◽  
Jonathan Cudnik ◽  
Cristyn Watkins
Keyword(s):  
Cervical Cancer ◽  
Cancer Prevention ◽  
Cervical Cancer Prevention ◽  
Spanish Speaking ◽  
Educational Videos ◽  
The Impact

HPV TESTING IN CERVICAL CANCER PREVENTION

2012 ◽  
pp. 5-14
Author(s):  
Vu Quoc Huy Nguyen
Keyword(s):  
Cervical Cancer ◽  
High Risk ◽  
Cancer Prevention ◽  
Clinical Application ◽  
Vaccine Coverage ◽  
Cervical Cancer Prevention ◽  
Control Mechanisms ◽  
Hpv Test ◽  
Hpv Types ◽  
The Impact

Despite the introduction of HPV vaccines and its clinical application expanded during the last decade with increasing vaccine coverage, cervical cancer prevention still requires continuing and widespread screening activity. Based on the knowledge about the impact of HPV on cell cycle control mechanisms, tests for detection of HPV DNA, host cellular proteins or HPV proteins have been developed and introduced to clinical application. Among them, tests able to detect DNA of high-risk HPVs have been widely used worldwide and start to be evidenced as a valuable screening test in cervical cancer prevention. Hybrid Capture II (HCII, Qiagen, USA) using DNA hybridization and signals amplification technique is the FDA and EC approved test, which can detect and differentiated any type from 13 high-risk HPV types (16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 and 68) and 5 low-risk HPV types (6, 11, 42, 43, 44). The introduction of a newly developed HPV test using simpler technology and affordable cost - careHPV - and its commercialization in the very near future, in combination with visual inspection with acetic acid and/or colposcopy will allow the implementation of new approaches with higher coverage and a more effective strategy of screening – diagnosis – management.

scholarly journals Hitting the Pause Button: The Impact of COVID-19 on Cervical Cancer Prevention, Screening and Treatment Access in Indonesia

2020 ◽  
Vol 5 (S1) ◽  
pp. 255-257
Author(s):  
Belinda Rina Marie Spagnoletti ◽  
Hanum Atikasari ◽  
Linda Rae Bennett ◽  
Henny M.A.R. Putri ◽  
Miranda Rachellina ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Cancer Prevention ◽  
Screening Program ◽  
Hpv Vaccination ◽  
Cancer Control ◽  
Future Generation ◽  
Cervical Cancer Prevention ◽  
Treatment Access ◽  
Life Saving ◽  
The Impact

As Indonesia grapples with COVID-19, it remains vital that other crucial health interventions continue to be prioritised to minimise the overall health footprint of the epidemic. Cervical cancer is a preventable disease, yet it is the most lethal female cancer in Indonesia, responsible for more than 18,000 deaths each year. Thanks to the efforts of several key groups driving health reforms to step up cervical cancer control in recent years, Indonesia has a national screening program and, up until late 2019, a HPV vaccination pilot program was being rolled out across five provinces. An interdisciplinary four-year study exploring the experiences of and health system responses to cervical cancer in Indonesia was underway when the COVID-19 pandemic emerged. Alarmingly, the widespread restrictions on citizens’ mobility and the redistribution of resources to the COVID-19 response has resulted in key services for cervical cancer prevention and screening being paused indefinitely, without a clear path forward. Treat ent seeking, and the availability of support services for women with a cervical cancer diagnosis have also been interrupted. If unaddressed, these pauses will lead to an increase in women presenting with late stage cervical cancer, for which treatment is more invasive and costly, with a lower chance of survival. We are also concerned for the future generation of women in Indonesia, who, without access to affordable HPV vaccination, will face a heightened risk of developing cervical cancer compared with their peers from countries that have prioritised investing in this life saving vaccine.

Sign in / Sign up

Export Citation Format

Share Document